Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients

Update Il y a 4 ans
Reference: NCT00635765

Woman and Man

Extract

The purpose of this study is to assess the safety profile of C2L-OCT-01 PR for up to an additional 96-week period in acromegalic patients who completed the C2L-OCT-01 PR-301 study.


Inclusion criteria

  • Acromegaly


Links